SCHEMBL13064970

SCHEMBL13064970

COc1cc(C(=O)Oc2cc(O)cc(C(=O)O)c2)cc(OC)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
TPMT P51580 1/20 0.56
MAPT P10636 4/20 0.53
POLB P06746 4/20 0.50
ALDH1A1 P00352 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA3 P07451 1/20 0.50
PKM P14618 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA5A P35218 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
CA5B Q9Y2D0 1/20 0.50
TSHR P16473 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
3,4,5-Trimethoxybenzoic Acid SCHEMBL6559147 0.85 TPMT (0.71) TPMTMAPTPOLBCA12CA1
SCHEMBL618766 0.83 CA12 (0.61) MEN1KMT2AMAPTPOLBALDH1A1
SCHEMBL9970898 0.83 MEN1 (0.81) MEN1KMT2ATPMTMAPTPOLB
3,4,5-Trimethoxybenzoic Acid SCHEMBL6592 0.79 TPMT (0.78) KMT2ATPMTMAPTALDH1A1CA12
SCHEMBL13266325 0.79 MEN1 (0.74) MEN1KMT2AMAPTPOLBALDH1A1
SCHEMBL13064968 0.78 MAPT (0.74) MEN1KMT2AMAPTPOLBALDH1A1
SCHEMBL21465837 0.78 CA12 (0.58) MEN1KMT2AMAPTPOLBALDH1A1
3,4,5-Trimethoxybenzoic Acid SCHEMBL10838612 0.78 TPMT (0.75) KMT2ATPMTMAPTALDH1A1CA12
3,4,5-Trimethoxybenzoic Acid SCHEMBL11023602 0.78 TPMT (0.75) KMT2ATPMTMAPTALDH1A1CA12
3,4,5-Trimethoxybenzoic Acid SCHEMBL9739818 0.78 TPMT (0.75) KMT2ATPMTMAPTALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MEN1 3364/4885KMT2A 4381/4885TPMT 3617/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 MEN1 3364/4885KMT2A 4381/4885TPMT 3617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.